Allarity Therapeutics, Inc.
ALLR
$1.61
-$0.15-8.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.10M | -23.40M | -24.52M | -18.78M | -11.64M |
| Total Depreciation and Amortization | 29.00K | 18.00K | 9.00K | 17.00K | 21.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.07M | 7.73M | 7.11M | 3.33M | -5.09M |
| Change in Net Operating Assets | -2.82M | -2.99M | 49.00K | -379.00K | 961.00K |
| Cash from Operations | -16.82M | -18.64M | -17.35M | -15.82M | -15.75M |
| Capital Expenditure | -298.00K | -298.00K | -298.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -298.00K | -298.00K | -298.00K | -- | -- |
| Total Debt Issued | 0.00 | 0.00 | 1.34M | 1.34M | 1.34M |
| Total Debt Repaid | 0.00 | -1.34M | -1.34M | -1.34M | -1.69M |
| Issuance of Common Stock | 20.81M | 48.46M | 37.35M | 33.64M | 40.01M |
| Repurchase of Common Stock | -2.57M | -- | -- | -- | -- |
| Issuance of Preferred Stock | 2.94M | 2.94M | 2.94M | 2.94M | 0.00 |
| Repurchase of Preferred Stock | -3.50M | -3.50M | -3.50M | -3.50M | -5.00M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.68M | 46.56M | 36.79M | 33.08M | 34.66M |
| Foreign Exchange rate Adjustments | -2.00M | -226.00K | 225.00K | -197.00K | -97.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.43M | 27.39M | 19.37M | 17.06M | 18.81M |